Senior Consultant
RQM+
Anastassia is a regulatory and technical leader in the MedTech and biopharmaceutical consulting space. At RQM+, she has served as a trusted expert in regulatory strategy for PMCF survey design throughout the EU MDD to MDR transition. Most recently, she supports scientific and medical writing for clinical trials spanning surgical invasive devices to pharmaceutical interventions and biologics. Anastassia has over 10 years of clinical and technical experience in research, patient-reported outcomes, and the interpretation of real-world data.
Chasing an Easier Method for Specific PMPF: Can Surveys Play a Role?
Friday, March 6, 2026
2:00 PM - 3:00 PM East Coast USA Time